Skip to main content
. 2019 Jul 8;2019:5958032. doi: 10.1155/2019/5958032

Table 4.

Investigation profiles of patients.

Investigation Frequency (%)
Ascitic gram stain (n=24) Positive 2(8.3)
Negative 22(91.7)
Ascitic AFB stain (n=24) Yes 0(0)
No 24(100)
Hepatitis B surface antigen (n=52) Not determined 10(19.2)
Positive 9(17.3)
Negative 33(63.5)
Anti-Hepatitis C antibody (n=52) Not determined 11(21.2)
Yes 4(7.7)
No 37(71.2)
Antinuclear antibody (n=52) Not determined 50(96.2)
Negative 2(3.8)
HIV test (n=52) Not determined 39(75)
Positive 2(3.8)
Negative 11(21.2)